Literature DB >> 28511552

R147W in PROC Gene Is a Risk Factor of Thromboembolism in Thai Children.

Nongnuch Sirachainan1, Ampaiwan Chuansumrit1, Werasak Sasanakul1, Najwa Yudhasompop1,2, Lalita Mahaklan1, Jarin Vaewpanich1, Pimlak Charoenkwan3, Somjai Kanjanapongkul4, Anannit Visudtibhan1, Pakawan Wongwerawattanakoon5.   

Abstract

The p.R147W mutation, the c.C6152T in exon 7, causing a change in amino acid from arginine to tryptophan of the PROC gene has been reported as a common mutation in Taiwanese populations with venous thromboembolism (VTE). The present study aimed to identify the prevalence of p.R147W in the Thai population and children with TE and the risk of developing TE. Patients aged ≤18 years diagnosed with TE were enrolled. The PROC gene was amplified by polymerase chain reaction using a specific primer in exon 7. The restriction fragment length polymorphism was designed using MwoI restriction enzyme. A total of 184 patients and 690 controls were enrolled. The most common diagnosis of TE was arterial ischemic stroke (AIS), at 100 (54.3%), followed by VTE, at 38 (20.6%), and cerebral venous sinus thrombosis (CVST), at 23 (12.5%). The prevalence of heterozygous and homozygous p.R147W in patients and controls was 9.5% versus 5.8% and 2.7% versus 0.1%, respectively. Heterozygous p.R147W had odds ratios (ORs) of 1.8 (95% confidence interval [CI]: 1.0-3.2, P = .04), 3.2 (95% CI: 1.2-8.2, P = .009), and 4.5 (95% CI: 1.6-12.8, P = .002) of developing overall TE, VTE, and CVST, respectively. Homozygous p.R147W had ORs of 20.2 (95% CI: 2.3-173.7, P < .001), 21.4 (95% CI: 2.2-207.9, P < .001), and 43.3 (95% CI: 3.8-490.6, P < .001) of developing overall TE, AIS, and CVST, respectively. This study suggested that p.R147W is a common mutation and increased risk of TE in Thai children.

Entities:  

Keywords:  Thai; children; p.R147W; protein C deficiency; risk factor; thromboembolism

Mesh:

Substances:

Year:  2017        PMID: 28511552      PMCID: PMC6714681          DOI: 10.1177/1076029617709085

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  4 in total

1.  C-terminal residues of activated protein C light chain contribute to its anticoagulant and cytoprotective activities.

Authors:  Atsuki Yamashita; Yuqi Zhang; Michel F Sanner; John H Griffin; Laurent O Mosnier
Journal:  J Thromb Haemost       Date:  2020-03-05       Impact factor: 5.824

2.  Identification of Alpha Thalassemia, RNF213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome.

Authors:  Lunliya Thampratankul; Yusuke Okuno; Patcharee Komvilaisak; Duangrurdee Wattanasirichaigoon; Nongnuch Sirachainan
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-07-01       Impact factor: 3.122

3.  Racial differences in protein S Tokushima and two protein C variants as genetic risk factors for venous thromboembolism.

Authors:  Hiroko Tsuda; Kenta Noguchi; Doyeun Oh; Zsuzsanna Bereczky; Lai H Lee; Dongchon Kang; Luci M S Dusse; Maria das G Carvalho; Eriko Morishita
Journal:  Res Pract Thromb Haemost       Date:  2020-10-20

4.  PROC Promoter Single Nucleotide Polymorphisms Associated With Low Protein C Activity But Not Increased Risk of Thromboembolism in Pediatric Population.

Authors:  Natsumon Udomkittivorakul; Werasak Sasanakul; Jakris Eu-Ahsunthornwattana; Ampaiwan Chuansumrit; Patcharee Komwilaisak; Duantida Songdej; Nongnuch Sirachainan
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.